Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery (Q28297411)

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Developments in the management of uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Prognostic parameters in uveal melanoma: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Lymphocytic infiltration in uveal malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Abnormal cell cycle regulation in primary human uveal melanoma cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Molecular genetics of uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

The biology of the post-genomic era: the proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Correlation between protein and mRNA abundance in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

From genomics to proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Clinical proteomics: translating benchside promise into bedside reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Advances in protein solubilisation for two-dimensional electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Direct analysis of protein complexes using mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Mass spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Electrospray ionization for mass spectrometry of large biomolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Mass spectrometry in proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Analysis of proteins and proteomes by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Applying proteomics technology to platelet research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Developments in mass spectrometry for the analysis of complex protein mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

SELDI ProteinChip® Array Technology: Protein-Based Predictive Medicine and Drug Discovery Applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Clinical proteomics and mass spectrometry profiling for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Role of oncoproteomics in the personalized management of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Cancer proteomics: Serum diagnostics for tumor marker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Cancer proteomics: from signaling networks to tumor markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis--preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Strategies for plasma proteomic profiling of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Human body fluid proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Proteomics in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

The role of CD146 (Mel-CAM) in biology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Cellular adhesion pathways and metastatic potential of human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

High-mobility group protein 1(Y): metastasis-associated or metastasis-inducing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Differential control of apoptosis by DJ-1 in prostate benign and cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Sample preparation of human serum for the analysis of tumor markers. Comparison of different approaches for albumin and gamma-globulin depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Fine-needle aspiration in PreservCyt: a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Analysis of Bcl-2 protein expression in choroidal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Deregulation of the Rb and p53 pathways in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Unpulsed dendritic cells induce broadly applicable anti-tumor immunity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Implication of stem cell factor in the proliferation of choroidal melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Sequence analysis and high-throughput immunohistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

The role of c-kit and imatinib mesylate in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

C-myc oncogene expression in ocular melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Telomerase expression in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Expression of insulin-like growth factor receptor (IGF-1R), c-Fos, and c-Jun in uveal melanoma: an immunohistochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Expression of somatostatin receptors in uveal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

5-S-cysteinyldopa as diagnostic tumor marker for uveal malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Molecular determinants of human uveal melanoma invasion and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

The prognostic significance of c-myc oncogene expression in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.4.2.273

21 January 2018

Identifiers

DOI

10.1586/14789450.4.2.273

1 reference

Consolidated OpenCitations Corpus – April 2017

release_lefbmemvlzd6bnkazbfbzqoane

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lefbmemvlzd6bnkazbfbzqoane

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17425462

1 reference

Consolidated OpenCitations Corpus – April 2017